AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34195206 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term low-dose lithium therapy for three consecutive days
Number of subjects: 0
Study 34195206 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for three consecutive days
Number of subjects: 0
Study 34649083 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic clinical pathway (CPW)
Number of subjects: 156
Study 34649083 — intervention group
Group type: COMPARATOR
Intervention: Control 'treatment as usual' (TAU)
Number of subjects: 156
Study 35790596 — intervention group
Group type: EXPERIMENTAL
Intervention: CUES© intervention, 72% attendance at 4–8 sessions
Number of subjects: 50
Study 35790596 — intervention group
Group type: COMPARATOR
Intervention: Enhanced services as usual
Number of subjects: 50
Study 34473448 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp text messaging and motivational individual counseling, sent 3 days a week.
Number of subjects: 50
Study 34473448 — intervention group
Group type: COMPARATOR
Intervention: Control group (no WhatsApp text messaging or counseling).
Number of subjects: 50
Study 34473448 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp text messaging and motivational individual counseling.
Number of subjects: 50
Study 32603494 — intervention group
Group type: EXPERIMENTAL
Intervention: Somapacitan
Number of subjects: 62
Study 32603494 — intervention group
Group type: COMPARATOR
Intervention: Daily GH
Number of subjects: 62
Study 35678020 — intervention group
Group type: EXPERIMENTAL
Intervention: Argatroban plus dual antiplatelet therapy (DAPT)
Number of subjects: 120
Study 35678020 — intervention group
Group type: COMPARATOR
Intervention: DAPT only (control group)
Number of subjects: 120
Study 33337738 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadoterate administration after premedication with corticosteroid and diphenhydramine
Number of subjects: 26
Study 33337738 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadoterate administration with corticosteroid premedication
Number of subjects: 26
Study 33337738 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadoterate administration without corticosteroid premedication
Number of subjects: 26
Study 32925623 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg oral E2 with or without vaginal progesterone
Number of subjects: 275
Study 35177066 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (100,000 IU)
Number of subjects: 543
Study 35177066 — intervention group
Group type: COMPARATOR
Intervention: Control (nothing)
Number of subjects: 543
Study 34358724 — intervention group
Group type: EXPERIMENTAL
Intervention: Sintilimab plus chemotherapy
Number of subjects: 397
Study 34358724 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus chemotherapy
Number of subjects: 397
Study 32058077 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatar-Simon task with rapidly changing avatar positions and simultaneous presentations
Number of subjects: 0
Study 32058077 — intervention group
Group type: EXPERIMENTAL
Intervention: Avatar-Simon task with rapidly changing avatar positions and non-simultaneous presentations
Number of subjects: 0
Study 34098728 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal physical vibrational lithecbole (EPVL) through greater sciatic foramen (GSF)
Number of subjects: 181
Study 34098728 — intervention group
Group type: COMPARATOR
Intervention: Abdominal treatment
Number of subjects: 181
Study 34098728 — intervention group
Group type: COMPARATOR
Intervention: Combined with oral use of tamsulosin at 0.4 mg daily
Number of subjects: 181
Study 33091320 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker home visits
Number of subjects: 1469
Study 33091320 — intervention group
Group type: COMPARATOR
Intervention: Standard clinic care
Number of subjects: 1469
Study 34875413 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous infant with maternally reported respiratory morbidity
Number of subjects: 1412
Study 34875413 — intervention group
Group type: COMPARATOR
Intervention: No previous infant with maternally reported respiratory morbidity
Number of subjects: 1412
Study 34875413 — intervention group
Group type: EXPERIMENTAL
Intervention: No betamethasone use
Number of subjects: 1412
Study 34875413 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone use
Number of subjects: 1412
Study 33683016 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug being tested to prevent hypertensive complications
Number of subjects: 1
Study 33683016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 32819842 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta 10.0 µg
Number of subjects: 1591
Study 32819842 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta 10.3 µg
Number of subjects: 1591
Study 32819842 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta 9.7 µg
Number of subjects: 1591
Study 32819842 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta 9.3 µg
Number of subjects: 1591
Study 32819842 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta 9.5–10.4 µg
Number of subjects: 1591
Study 32819842 — intervention group
Group type: COMPARATOR
Intervention: 150 IU/day follitropin alfa
Number of subjects: 1591
Study 34298007 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐hookah vaping
Number of subjects: 17
Study 34298007 — intervention group
Group type: COMPARATOR
Intervention: combustible hookah smoking
Number of subjects: 17
Study 32897605 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE)
Number of subjects: 34
Study 35246827 — intervention group
Group type: EXPERIMENTAL
Intervention: fosnetupitant 235 mg
Number of subjects: 785
Study 35246827 — intervention group
Group type: COMPARATOR
Intervention: fosaprepitant 150 mg
Number of subjects: 785
Study 33871574 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in saturated fatty acids from cheese
Number of subjects: 92
Study 33871574 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in saturated fatty acids from butter
Number of subjects: 92
Study 33871574 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in monounsaturated fatty acids (MUFAs)
Number of subjects: 92
Study 33871574 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in n‐6 polyunsaturated fatty acids (PUFAs)
Number of subjects: 92
Study 33871574 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet higher in carbohydrates (CHO)
Number of subjects: 92
Study 33871574 — intervention group
Group type: COMPARATOR
Intervention: All diets
Number of subjects: 92
Study 35866500 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertile 3 (T3) average 1-year home blood pressure
Number of subjects: 242
Study 35866500 — intervention group
Group type: EXPERIMENTAL
Intervention: Average 1-year home blood pressure
Number of subjects: 242
Study 33674863 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease self-management app delivering 1-2 tailored messages/day for 16 weeks
Number of subjects: 110
Study 32740469 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 0
Study 32740469 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 0
Study 35220498 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised passive trunk stretching using the exercise ball (EB)
Number of subjects: 12
Study 35220498 — intervention group
Group type: COMPARATOR
Intervention: Resting and sitting trial (CON)
Number of subjects: 12
Study 32756282 — intervention group
Group type: EXPERIMENTAL
Intervention: High hand grip strength (HGS) group (n=26)
Number of subjects: 78
Study 32756282 — intervention group
Group type: COMPARATOR
Intervention: Low hand grip strength (HGS) group (n=52)
Number of subjects: 78
Study 36038180 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutri-Score
Number of subjects: 1180
Study 36038180 — intervention group
Group type: COMPARATOR
Intervention: Reference Intakes (RIs)
Number of subjects: 1180
Study 36038180 — intervention group
Group type: COMPARATOR
Intervention: No label
Number of subjects: 1180
Study 36038180 — intervention group
Group type: COMPARATOR
Intervention: RIs
Number of subjects: 1180
Study 32062872 — intervention group
Group type: EXPERIMENTAL
Intervention: OIR trials (Other-Initiated Repairs)
Number of subjects: 88
Study 32062872 — intervention group
Group type: COMPARATOR
Intervention: Trials without OIR
Number of subjects: 88
Study 32062872 — intervention group
Group type: EXPERIMENTAL
Intervention: OIR trials
Number of subjects: 88
Study 32062872 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated social interactions
Number of subjects: 88
Study 32062872 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall communication
Number of subjects: 88
Study 33413569 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific acupoints group
Number of subjects: 60
Study 33413569 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-specific acupoints group
Number of subjects: 60
Study 33413569 — intervention group
Group type: COMPARATOR
Intervention: Non-acupoints group
Number of subjects: 60
Study 36127077 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ICU-VR group (ICU-VR within 2 weeks after ICU discharge)
Number of subjects: 300
Study 36127077 — intervention group
Group type: EXPERIMENTAL
Intervention: Late ICU-VR group (ICU-VR during the post-ICU follow-up visit)
Number of subjects: 300
Study 36127077 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (including a mandatory ICU follow-up clinic visit 3 months after ICU discharge)
Number of subjects: 300
Study 36127077 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (early ICU-VR, late ICU-VR, and usual care)
Number of subjects: 300
Study 34020596 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 120
Study 34020596 — intervention group
Group type: COMPARATOR
Intervention: Conventional Fluid Therapy (CFT)
Number of subjects: 120
Study 32928560 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin 75 μg/ml (Q75)
Number of subjects: 212
Study 32928560 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin 150 μg/ml (Q150)
Number of subjects: 212
Study 32928560 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin 300 μg/ml (Q300)
Number of subjects: 212
Study 32928560 — intervention group
Group type: COMPARATOR
Intervention: Sodium fluoride (NaF)
Number of subjects: 212
Study 32928560 — intervention group
Group type: COMPARATOR
Intervention: Control (deionized water, ethanol, chlorhexidine, EGCG)
Number of subjects: 212
Study 33413030 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg·kg‐1)
Number of subjects: 10
Study 33413030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 33979577 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass hybrid (GH; EQUIA Forte Fil/EQUIA Forte Coat)
Number of subjects: 88
Study 33979577 — intervention group
Group type: COMPARATOR
Intervention: Resin composite (RC; OptiBond FL/Filtek Supreme XTE)
Number of subjects: 88
Study 32122219 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra once daily (N=33)
Number of subjects: 99
Study 32122219 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra twice daily (N=31)
Number of subjects: 99
Study 32122219 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra (both dosing regimens combined)
Number of subjects: 99
Study 32122219 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N=35)
Number of subjects: 99
Study 35470813 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-care cognitive behavioral therapy for tinnitus
Number of subjects: 403
Study 33545015 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexavalent rotavirus vaccine
Number of subjects: 200
Study 33545015 — intervention group
Group type: COMPARATOR
Intervention: Placebo 1
Number of subjects: 200
Study 33545015 — intervention group
Group type: COMPARATOR
Intervention: Placebo 2
Number of subjects: 200
Study 32684465 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% purple corn pigment
Number of subjects: 0
Study 32684465 — intervention group
Group type: COMPARATOR
Intervention: Control (without purple corn pigment)
Number of subjects: 0
Study 35768167 — intervention group
Group type: EXPERIMENTAL
Intervention: SCPB with 10 mL of 0.5% ropivacaine
Number of subjects: 106
Study 35768167 — intervention group
Group type: COMPARATOR
Intervention: Control with 0.9% normal saline
Number of subjects: 106
Study 33938829 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer Lactate
Number of subjects: 80
Study 33938829 — intervention group
Group type: COMPARATOR
Intervention: Plasmalyte‐A
Number of subjects: 80
Study 32331033 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasotraline 6 mg/d
Number of subjects: 486
Study 32331033 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasotraline 4 mg/d
Number of subjects: 486
Study 32331033 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 486
Study 616083736 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (1.25 mg/0.05 mL)
Number of subjects: 40
Study 616083736 — intervention group
Group type: COMPARATOR
Intervention: Low-dose bevacizumab (0.625 mg/0.025 mL) combined with low-dose triamcinolone (1 mg/0.025 mL)
Number of subjects: 40
Study 35089202 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized fentanyl citrate
Number of subjects: 0
Study 35089202 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study 34810296 — intervention group
Group type: EXPERIMENTAL
Intervention: TJP-008 (1-day split dose)
Number of subjects: 293
Study 34810296 — intervention group
Group type: EXPERIMENTAL
Intervention: TJP-008 (2-day split dose)
Number of subjects: 293
Study 34810296 — intervention group
Group type: COMPARATOR
Intervention: 2L PEG with ascorbate (2-day split dose)
Number of subjects: 293
Study 32253388 — intervention group
Group type: EXPERIMENTAL
Intervention: Television distraction
Number of subjects: 69
Study 32253388 — intervention group
Group type: COMPARATOR
Intervention: Tell-Show-Do (TSD)
Number of subjects: 69
Study 35196481 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunbeam program (two 1-hour sessions/week of tailored and progressive resistance and balance training for 25 weeks followed by two 30-min sessions/week of nonprogressive exercise for 6 months)
Number of subjects: 148
Study 35196481 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunbeam program
Number of subjects: 148
Study 35196481 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 148
Study 33150732 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored habituation protocol for MRI including gradual exposure to scanner noise, social stories booklet, positive incentive strategies, and Play Therapy support
Number of subjects: 31
Study 33150732 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored habituation protocol for MRI
Number of subjects: 31
Study 33983868 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 patients
Number of subjects: 45
Study 33983868 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 45
Study 32044802 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior suprascapular block with 15 ml of ropivacaine 0.5% and epinephrine
Number of subjects: 140
Study 32044802 — intervention group
Group type: COMPARATOR
Intervention: Interscalene block with 15 ml of ropivacaine 0.5% and epinephrine
Number of subjects: 140
Study 32044802 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined superior trunk (C5‐C6 dermatomes) blockade
Number of subjects: 140
Study 36239376 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-Belt Treadmill (SBT) training
Number of subjects: 52
Study 36239376 — intervention group
Group type: COMPARATOR
Intervention: Tied-Belt Treadmill (TBT) training
Number of subjects: 52
Study 36239376 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-Belt Treadmill (SBT) training and Tied-Belt Treadmill (TBT) training
Number of subjects: 52
Study 33441355 — intervention group
Group type: EXPERIMENTAL
Intervention: SPA intervention (10 weekly singing group sessions led by a music facilitator)
Number of subjects: 41
Study 33441355 — intervention group
Group type: EXPERIMENTAL
Intervention: SPA intervention
Number of subjects: 41
Study 33441355 — intervention group
Group type: COMPARATOR
Intervention: Control (aphasia information resource pack)
Number of subjects: 41
Study 35926824 — intervention group
Group type: EXPERIMENTAL
Intervention: GSP301 nasal spray (olopatadine hydrochloride 665 μg and mometasone furoate 25 μg), 1 spray/each nostril twice daily for 14 days
Number of subjects: 446
Study 35926824 — intervention group
Group type: EXPERIMENTAL
Intervention: GSP301 nasal spray
Number of subjects: 446
Study 35926824 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 446
Study 34282929 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycelial plugs (5 mm diameter) from Sclerotinia isolates SN1 and SN2 inoculated on healthy ginseng roots.
Number of subjects: 1000
Study 34282929 — intervention group
Group type: COMPARATOR
Intervention: Negative control using PDA plugs without mycelia.
Number of subjects: 1000
Study 34741249 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary team (MDT) care
Number of subjects: 140
Study 34741249 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140
Study 34741249 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT care
Number of subjects: 140
Study 35377820 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 20
Study 35377820 — intervention group
Group type: COMPARATOR
Intervention: Stretching and toning (SAT)
Number of subjects: 20
Study 35377820 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Mobile Trainer (PMT)
Number of subjects: 20
Study 32011642 — intervention group
Group type: EXPERIMENTAL
Intervention: tPA and DNase (4 mg tPA and 5 mg DNase)
Number of subjects: 97
Study 32011642 — intervention group
Group type: COMPARATOR
Intervention: tPA and placebo (5 mL normal saline)
Number of subjects: 97
Study 32011642 — intervention group
Group type: EXPERIMENTAL
Intervention: tPA and DNase
Number of subjects: 97
Study 32011642 — intervention group
Group type: COMPARATOR
Intervention: tPA and placebo
Number of subjects: 97
Study 35883930 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded functional strengthening exercises program using a shoe supporter to maintain a plantigrade foot position
Number of subjects: 72
Study 35883930 — intervention group
Group type: COMPARATOR
Intervention: Specially designed physical therapy program
Number of subjects: 72
Study 33338740 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-disclosure intervention (GSDI)
Number of subjects: 40
Study 33338740 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 36099189 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-customized avatar condition
Number of subjects: 60
Study 36099189 — intervention group
Group type: COMPARATOR
Intervention: Assigned avatar condition
Number of subjects: 60
Study 33950223 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity intervention targeting canteen managers
Number of subjects: 162
Study 33950223 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium intensity intervention targeting canteen managers
Number of subjects: 162
Study 33950223 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity intervention targeting canteen managers
Number of subjects: 162
Study 32358310 — intervention group
Group type: EXPERIMENTAL
Intervention: Free weights
Number of subjects: 46
Study 32358310 — intervention group
Group type: COMPARATOR
Intervention: Machines
Number of subjects: 46
Study 35819944 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzathine penicillin G (BPG)
Number of subjects: 823
Study 35819944 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (DOXY)
Number of subjects: 823
Study 32572611 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional counseling
Number of subjects: 0
Study 32572611 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory counseling
Number of subjects: 0
Study 32723114 — intervention group
Group type: EXPERIMENTAL
Intervention: Amplatz renal dilator
Number of subjects: 88
Study 32723114 — intervention group
Group type: COMPARATOR
Intervention: Visual internal urethrotomy (cold knife)
Number of subjects: 88
Study 34113095 — intervention group
Group type: EXPERIMENTAL
Intervention: Nemiralisib 750 µg
Number of subjects: 938
Study 34113095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 938
Study 34113095 — intervention group
Group type: EXPERIMENTAL
Intervention: Nemiralisib (all doses)
Number of subjects: 938
Study 34113095 — intervention group
Group type: EXPERIMENTAL
Intervention: Nemiralisib
Number of subjects: 938
Study 32126995 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Locking Blade Plate (DLBP)
Number of subjects: 266
Study 32126995 — intervention group
Group type: COMPARATOR
Intervention: Dynamic Hip Screw (DHS)
Number of subjects: 266
Study 33205847 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot group (RG)
Number of subjects: 56
Study 33205847 — intervention group
Group type: COMPARATOR
Intervention: Free-hand group (FG)
Number of subjects: 56
Study 32028795 — intervention group
Group type: EXPERIMENTAL
Intervention: Preheated chlorhexidine in 70% ethanol (36°C)
Number of subjects: 220
Study 32028795 — intervention group
Group type: COMPARATOR
Intervention: Room temperature chlorhexidine in 70% ethanol (20°C)
Number of subjects: 220
Study 34325670 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol 25mcg every 2 hours
Number of subjects: 520
Study 34325670 — intervention group
Group type: COMPARATOR
Intervention: Intravenous oxytocin (titrated)
Number of subjects: 520
Study 33006564 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentive eating smartphone app
Number of subjects: 38
Study 36171028 — intervention group
Group type: EXPERIMENTAL
Intervention: +Stay Active intervention (motivational interviewing combined with the Stay‐Active smartphone application)
Number of subjects: 60
Study 34006551 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Tai Chi postural training (TPT)
Number of subjects: 120
Study 34006551 — intervention group
Group type: COMPARATOR
Intervention: Bobath rehabilitation training
Number of subjects: 120
Study 32894238 — intervention group
Group type: EXPERIMENTAL
Intervention: ELDOA
Number of subjects: 40
Study 32894238 — intervention group
Group type: COMPARATOR
Intervention: Post-facilitation stretching
Number of subjects: 40
Study 35220473 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (4 mg, n = 419)
Number of subjects: 841